Keywords
Last Name

Christopher J. Gill, MD

TitleAssociate Professor
InstitutionBoston University School of Public Health
DepartmentGlobal Health
Address801 Massachusetts Ave Crosstown Center
Boston MA 02118
Phone(617) 638-6584
ORCID ORCID Icon0000-0003-3353-0617
 Awards and Honors

Start-EndDescription
2016Boston University: Metcalf Cup and Prize for Excellence in Teaching
2015Boston University School of Public Health: Norman Scotch Award For Excellence In Teaching
 Research Expertise & Professional Interests
Christopher Gill has an MD from the University of Massachusetts Medical School and an MS from Tufts-Sackler School of Graduate Biomedical Studies.Dr. Gill is an infectious disease specialist by training. From 2002-2008 he was a faculty member of the Department of Global Health at Boston University School of Public Health, engaged in a wide variety of clinical trials and investigations. His research interests have focused on child survival, and include diarrheal diseases, tuberculosis, pneumococcal and meningococcal disease, adherence to HIV medications, and neonatal survival. He was the principal investigator of the Lufwanyama Neonatal Survival Project in Northern Zambia (LUNESP), a prospective, cluster randomized and controlled effectiveness study designed to determine whether training traditional birth attendants to manage several common perinatal conditions could reduce neonatal mortality in the setting of a resource poor country with limited access to healthcare. The results demonstrated that training traditional birth attendants in neonatal resuscitation skills significantly reduces neonatal mortality by approximately 50%. From 2008-end of 2010 he was the Director of the Meningitis ACWY conjugate vaccine clinical trials group at Novartis Vaccines. There he was responsible for the design, implementation and analysis of Phase IIb, III and IV clinical trials in support of the vaccine, and played a key role in licensing this new vaccine in over 60 countries around the world, including the US. In 2011, he rejoined the faculty at the BU Center for Global Health and Development and the BU School of Public Health, working as the Director of the BUSPH Pharmaceuticals Program from 2011-15, teaching, mentoring, and conducting research in the areas of HIV medication adherence in China, advocacy around child mortality due to diarrhea and pneumonia, pertussis disease surveillance in Zambia, and capacity building of Vietnamese community health workers using SMS text messaging.

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Brennan AT, Bonawitz R, Gill CJ, Thea DM, Long L, Fox MP. Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al. AIDS. 2017 Jan 14; 31(2):317. PMID: 28002088.
    View in: PubMed
  2. Lapidot R, Gill CJ. The resurgence of pertussis: putting together the pieces of the puzzle. BMC Tropical Diseases, Travel Medicine and Vaccines. 2016; 26(2).
  3. Gill CJ, Mwananyanda L, MacLeod W, Kwenda G, Mwale M, Williams AL, Siazeele K, Yang Z, Mwansa J, Thea DM. Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S154-S164. PMID: 27838668.
    View in: PubMed
  4. Gill CJ, Le Ngoc B, Halim N, Nguyen Viet H, Larson Williams A, Nguyen Van T, McNabb M, Tran Thi Ngoc L, Falconer A, An Phan Ha H, Rohr J, Hoang H, Michiel J, Nguyen Thi Thanh T, Bird L, Pham Vu H, Yeshitla M, Ha Van N, Sabin L. The mCME Project: A Randomized Controlled Trial of an SMS-Based Continuing Medical Education Intervention for Improving Medical Knowledge among Vietnamese Community Based Physicians' Assistants. PLoS One. 2016; 11(11):e0166293. PMID: 27861516.
    View in: PubMed
  5. Ragan EJ, Johnson C, Milton JN, Gill CJ. Ear biometrics for patient identification in global health: a cross-sectional study to test the feasibility of a simplified algorithm. BMC Res Notes. 2016 Nov 02; 9(1):484. PMID: 27806727.
    View in: PubMed
  6. Vian T, Bachman De Silva M, Cabral HJ, Williams GC, Gill CJ, Sabin L. . The role of motivation in predicting ART adherence in China. Journal of Health Psychology. 2016; DOI: 10DOI.1177/13591053166729.
  7. Brennan AT, Bonawitz R, Gill CJ, Thea DM, Kleinman M, Useem J, Garrison L, Ceccarelli R, Udokwu C, Long L, Fox MP. A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children. AIDS. 2016 Sep 24; 30(15):2351-60. PMID: 27456985.
    View in: PubMed
  8. Bachman DeSliva M, Gifford AL, Bonawitz R, Zhong L, Zhang F, Mu W, Li Y, Lu H Zeng X, Gill CJ, Sabin LL. . Real-time electronic drug monitoring (EDM) for HIV-positive adolescents: Promising acceptability and feasibility in China. J AIDS and Clinical Research. 2016; 7(7).
  9. Useem J, Brennan A, LaValley M, Vickery M, Ameli O, Reinen N, Gill CJ. Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis. PLoS One. 2015; 10(12):e0144980. PMID: 26671213.
    View in: PubMed
  10. Gill CJ, DeSilva MB, Hamer DH, Keyi X, Wilson IB, Sabin L. Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or "How the 'Broken Window' Theory Pertains to ART Adherence". AIDS Behav. 2015 Nov; 19(11):2057-68. PMID: 25893658.
    View in: PubMed
  11. Sabin LL, Bachman DeSilva M, Gill CJ, Zhong L, Vian T, Xie W, Cheng F, Xu K, Lan G, Haberer JE, Bangsberg DR, Li Y, Lu H, Gifford AL. Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology Study. J Acquir Immune Defic Syndr. 2015 Aug 15; 69(5):551-9. PMID: 25886927.
    View in: PubMed
  12. McNabb M, Chukwu E, Ojo O, Shekhar N, Gill CJ, Salami H, Jega F. Assessment of the quality of antenatal care services provided by health workers using a mobile phone decision support application in northern Nigeria: a pre/post-intervention study. PLoS One. 2015; 10(5):e0123940. PMID: 25942018.
    View in: PubMed
  13. Gill CJ. Plasmodium vivax malaria in the UK. BMJ. 2015; 350:h1840. PMID: 25882444.
    View in: PubMed
  14. Waldorf B, Gill C, Crosby SS. Assessing adherence to accepted national guidelines for immigrant and refugee screening and vaccines in an urban primary care practice: a retrospective chart review. J Immigr Minor Health. 2014 Oct; 16(5):839-45. PMID: 23512323.
    View in: PubMed
  15. Gill CJ, MacLeod WB, Phiri-Mazala G, Guerina NG, Mirochnick M, Knapp AB, Hamer DH. Can traditional birth attendants be trained to accurately identify septic infants, initiate antibiotics, and refer in a rural African setting? Glob Health Sci Pract. 2014 Aug; 2(3):318-27. PMID: 25276591.
    View in: PubMed
  16. Saito H, Gill CJ. How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database. PLoS One. 2014; 9(7):e101826. PMID: 25025477.
    View in: PubMed
  17. Ginsburg AS, Tinkham L, Riley K, Kay NA, Klugman KP, Gill CJ. Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis of three decades of published studies. Int J Antimicrob Agents. 2013 Dec; 42(6):482-91. PMID: 24139883.
    View in: PubMed
  18. Bachman Desilva M, Gifford AL, Keyi X, Li Z, Feng C, Brooks M, Harrold M, Yueying H, Gill CJ, Wubin X, Vian T, Haberer J, Bangsberg D, Sabin L. Feasibility and Acceptability of a Real-Time Adherence Device among HIV-Positive IDU Patients in China. AIDS Res Treat. 2013; 2013:957862. PMID: 23956851.
    View in: PubMed
  19. Gill CJ, Young M, Schroder K, Carvajal-Velez L, McNabb M, Aboubaker S, Qazi S, Bhutta ZA. Bottlenecks, barriers, and solutions: results from multicountry consultations focused on reduction of childhood pneumonia and diarrhoea deaths. Lancet. 2013 Apr 27; 381(9876):1487-98. PMID: 23582720.
    View in: PubMed
  20. Gill CJ, Hamer DH. Underpricing the competition in the other drug war: a novel strategy for combatting the inappropriate use of artemisinin monotherapies. Pathog Glob Health. 2013 Apr; 107(3):108-9. PMID: 23683363.
    View in: PubMed
  21. Waldorf B, Gill CJ, Crosby S. . Assessing adherence to accepted national guidelines for immigrant and refugee screening and vaccines in an urban primary care practice - a retrospective chart review. Journal of immigrant and minority health. 2013.
  22. Gill CJ. Novel assessment of a novel meningitis B vaccine. Lancet Infect Dis. 2013 May; 13(5):381-2. PMID: 23414710.
    View in: PubMed
  23. Aneni EC, Hamer DH, Gill CJ. Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease. Trop Med Int Health. 2013 Mar; 18(3):313-27. PMID: 23320577.
    View in: PubMed
  24. Gill CJ. How often do US-based human subjects research studies register on time, and how often do they post their results? A statistical analysis of the Clinicaltrials.gov database. BMJ Open. 2012; 2(4). PMID: 22936820.
    View in: PubMed
  25. Gill CJ, Guerina NG, Mulenga C, Knapp AB, Mazala G, Hamer DH. Training Zambian traditional birth attendants to reduce neonatal mortality in the Lufwanyama Neonatal Survival Project (LUNESP). Int J Gynaecol Obstet. 2012 Jul; 118(1):77-82. PMID: 22542215.
    View in: PubMed
  26. Sabin LL, Knapp AB, MacLeod WB, Phiri-Mazala G, Kasimba J, Hamer DH, Gill CJ. Costs and cost-effectiveness of training traditional birth attendants to reduce neonatal mortality in the Lufwanyama Neonatal Survival study (LUNESP). PLoS One. 2012; 7(4):e35560. PMID: 22545117.
    View in: PubMed
  27. Khatami A, Snape MD, Davis E, Layton H, John T, Yu LM, Dull PM, Gill CJ, Odrjlin T, Dobson S, Halperin SA, Langley JM, McNeil SA, Pollard AJ. Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations. Vaccine. 2012 Apr 16; 30(18):2831-8. PMID: 22394992.
    View in: PubMed
  28. Keiser PB; Gill CJ. Defining efficacy and safety of meningococcal vaccines. Clinical Investigations. 2012; 2(6):603-14.
  29. Klein NP, Reisinger KS, Johnston W, Odrljin T, Gill CJ, Bedell L, Dull P. Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants. Pediatr Infect Dis J. 2012 Jan; 31(1):64-71. PMID: 22094635.
    View in: PubMed
  30. Gill CJ, Ram S, Welsch JA, Detora L, Anemona A. Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source. Vaccine. 2011 Dec 9; 30(1):29-34. PMID: 22075087.
    View in: PubMed
  31. Gill CJ, Hamer DH, Knapp AB. Dispelling the myths surrounding traditional birth attendants. BMJ. 2011; 343:d4481; author reply d4477. PMID: 21771841.
    View in: PubMed
  32. Lee AC, Cousens S, Wall SN, Niermeyer S, Darmstadt GL, Carlo WA, Keenan WJ, Bhutta ZA, Gill C, Lawn JE. Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: a systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health. 2011; 11 Suppl 3:S12. PMID: 21501429.
    View in: PubMed
  33. Gill CJ, Phiri-Mazala G, Guerina NG, Kasimba J, Mulenga C, MacLeod WB, Waitolo N, Knapp AB, Mirochnick M, Mazimba A, Fox MP, Sabin L, Seidenberg P, Simon JL, Hamer DH. Effect of training traditional birth attendants on neonatal mortality (Lufwanyama Neonatal Survival Project): randomised controlled study. BMJ. 2011; 342:d346. PMID: 21292711.
    View in: PubMed
  34. Gill CJ, Baxter R, Anemona A, Ciavarro G, Dull P. Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents. Hum Vaccin. 2010 Nov; 6(11):881-7. PMID: 21339701.
    View in: PubMed
  35. Halperin SA, Gupta A, Jeanfreau R, Klein NP, Reisinger K, Walter E, Bedell L, Gill C, Dull PM. Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age. Vaccine. 2010 Nov 23; 28(50):7865-72. PMID: 20943209.
    View in: PubMed
  36. Sabin LL, DeSilva MB, Hamer DH, Xu K, Zhang J, Li T, Wilson IB, Gill CJ. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav. 2010 Jun; 14(3):580-9. PMID: 19771504.
    View in: PubMed
  37. Litzow JM, Gill CJ, Mantaring JB, Fox MP, MacLeod WB, Mendoza M, Mendoza S, Scobie R, Huskins CW, Goldman DA, Hamer DH. High frequency of multidrug-resistant gram-negative rods in 2 neonatal intensive care units in the Philippines. Infect Control Hosp Epidemiol. 2009 Jun; 30(6):543-9. PMID: 19435448.
    View in: PubMed
  38. Gill CJ, Sabin LL, Hamer DH, Keyi X, Jianbo Z, Li T, Wu WJ, Wilson IB, Desilva MB. Importance of dose timing to achieving undetectable viral loads. AIDS Behav. 2010 Aug; 14(4):785-93. PMID: 19353263.
    View in: PubMed
  39. Gill CJ, Mantaring JB, Macleod WB, Mendoza M, Mendoza S, Huskins WC, Goldmann DA, Hamer DH. Impact of enhanced infection control at 2 neonatal intensive care units in the Philippines. Clin Infect Dis. 2009 Jan 1; 48(1):13-21. PMID: 19025496.
    View in: PubMed
  40. Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH. Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study. Bull World Health Organ. 2008 Dec; 86(12):929-38. PMID: 19142293.
    View in: PubMed
  41. Sabin LL, Desilva MB, Hamer DH, Keyi X, Yue Y, Wen F, Tao L, Heggenhougen HK, Seton L, Wilson IB, Gill CJ. Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study. AIDS Care. 2008 Nov; 20(10):1242-50. PMID: 19012083.
    View in: PubMed
  42. Hamer DH, Gill CJ. Balancing individual benefit against public health risk: the impact of cotrimoxazole prophylaxis in HIV-infected patients on antimicrobial resistance. Am J Trop Med Hyg. 2008 Sep; 79(3):299-300. PMID: 18784218.
    View in: PubMed
  43. Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH. Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women. J Infect Dis. 2008 Apr 1; 197(7):1000-5. PMID: 18419536.
    View in: PubMed
  44. Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. J Infect Dis. 2007 Dec 1; 196(11):1585-94. PMID: 18008241.
    View in: PubMed
  45. Gill CJ, Macleod WB, Mwanakasale V, Chalwe V, Mwananyanda L, Champo D, Mukwamataba D, Chilengi R, Thea DM, Hamer DH. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. J Infect Dis. 2007 Dec 1; 196(11):1577-84. PMID: 18008240.
    View in: PubMed
  46. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007 Oct 16; 4(10):e298. PMID: 17941716.
    View in: PubMed
  47. Yanase Y, Ohida T, Kaneita Y, Agdamag DM, Leaño PS, Gill CJ. The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bull World Health Organ. 2007 Feb; 85(2):131-7. PMID: 17308734.
    View in: PubMed
  48. Gill CJ. Antiretroviral programme in rural Uganda. Lancet. 2006 Nov 4; 368(9547):1556-7. PMID: 17084742.
    View in: PubMed
  49. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006 Nov; 3(11):e438. PMID: 17121449.
    View in: PubMed
  50. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. Response to Bangsberg et al, regarding our Article "No Room for Complacency About Adherence to Antiretroviral Therapy in Africa". AIDS. 2006; 1(20):141-2.
  51. Gill CJ, Hamer DH. An uninvited dinner guest. Clin Infect Dis. 2005 Dec 15; 41(12):1764, 1810-1. PMID: 16304716.
    View in: PubMed
  52. Shnayderman M, Mansfield B, Yip P, Clark HA, Krebs MD, Cohen SJ, Zeskind JE, Ryan ET, Dorkin HL, Callahan MV, Stair TO, Gelfand JA, Gill CJ, Hitt B, Davis CE. Species-specific bacteria identification using differential mobility spectrometry and bioinformatics pattern recognition. Anal Chem. 2005 Sep 15; 77(18):5930-7. PMID: 16159124.
    View in: PubMed
  53. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. 2005 Aug 12; 19(12):1243-9. PMID: 16052078.
    View in: PubMed
  54. Gill CJ, Sabin L, Schmid CH. Why clinicians are natural bayesians. BMJ. 2005 May 7; 330(7499):1080-3. PMID: 15879401.
    View in: PubMed
  55. Gill CJ, Gill GC. Nightingale in Scutari: her legacy reexamined. Clin Infect Dis. 2005 Jun 15; 40(12):1799-805. PMID: 15909269.
    View in: PubMed
  56. Gill CJ, Jennings A, Newton J, Schwartz D. Fatal fulminant pancreatitis in a patient chronically treated with candesartan. Journal of pharmacy and technology. 2005; 2(21):79-82.
  57. Gill CJ, Sabin LL, Schmid CH. Why clinicians are natural Bayesians: Author’s reply. British Medical Journal. 2005; (330):1390.
  58. Gill CJ, Hamer DH. Coagulase negative staphylococcal ventriculo-peritoneal shunt infection treated with intravenous linezolid. Review Series Infectious Diseases in Sweden. 2005; 1(7):9-11.
  59. Gill CJ, Sabin LL, Tham J, Hamer DH. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection. Bull World Health Organ. 2004 Apr; 82(4):290-7. PMID: 15259258.
    View in: PubMed
  60. Gill CJ, Hamer DH. A primer on foodborne illness. Encyclopedia of gastroenterology. 2004.
  61. Gill CJ, Hamer D, Thea DM. Questions regarding the effectiveness of trimethoprim-sulfamethoxazole (cotrimoxazole) prophylaxis in African children. Clin Infect Dis. 2003 Sep 15; 37(6):863-4; author reply 864. PMID: 12955658.
    View in: PubMed
  62. Gill CJ, Lau J, Gorbach SL, Hamer DH. Diagnostic accuracy of stool assays for inflammatory bacterial gastroenteritis in developed and resource-poor countries. Clin Infect Dis. 2003 Aug 1; 37(3):365-75. PMID: 12884161.
    View in: PubMed
  63. Gill CJ, Mularski RM. Haemophilus aphrophilus purulent pericarditis, a case report and review of the literature. . Haemophilus aphrophilus purulent pericarditis, a case report and review of the literature. Infections in Medicine. 2003; 1(20):31-33.
  64. Gill CJ, Hamer DH, Thea DM. . Comments to the editor on Madhi et al, Clin. Inf. Dis. 35, 2002: Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral co-infections in African children with Pneumocystis carinii pneumonia. Clinical Infectious Diseases. 2003; 6(37).
  65. Gill CJ, Hamer DH, Lau J. Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis. JAMA. 2002 Dec 25; 288(24):3110-1; author reply 3112. PMID: 12495387.
    View in: PubMed
  66. Gill CJ, Hamer DH. "Doc, there's a worm in my stool": Munchausen parasitosis in a returning traveler. J Travel Med. 2002 Nov-Dec; 9(6):330-2. PMID: 12962590.
    View in: PubMed
  67. Gill CJ, Griffith JL, Jacobson D, Skinner S, Gorbach SL, Wilson IB. Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr. 2002 Aug 15; 30(5):485-92. PMID: 12154339.
    View in: PubMed
  68. Gill CJ, Murphy MA, Hamer DH. Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid. J Infect. 2002 Aug; 45(2):129-32. PMID: 12217722.
    View in: PubMed
  69. Hamer DH, Gill CJ. From the farm to the kitchen table: the negative impact of antimicrobial use in animals on humans. Nutr Rev. 2002 Aug; 60(8):261-4. PMID: 12199302.
    View in: PubMed
  70. Gill CJ, Hamer DH. Foodborne Illnesses. Curr Treat Options Gastroenterol. 2001 Feb; 4(1):23-38. PMID: 11177679.
    View in: PubMed
  71. Ellmore G, Phair WE, Gill CJ, Skinner D. Fluid delivery in ring porous trees. Journal of arboriculture. 1988; 10(14):233-39.
Christopher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department